Cédrick MOUSSAVOU

Gabon university of health sciences, Libreville

Published in 2022
EPILEPSY AND STIGMA IN AFRICA: VIEWPOINT OF HEALTHCARE PROFESSIONALS AND COMBAT STRATEGIES
Epilepsy, perception, stigma, health professionals
Authors: Médinatou Agbétou aIbrahimaFrançois Camara bcLansana Laho Diallo dAlmamy S Soumah dAdrien Constant _Fatima H Djibo rIbrahim Laminos _Youssoufa Maïga gZeinab Koné gMouhamadou Diagana fHamadi Hamadi fEetedal Ibrahim hJabang John eMoustapha Ndiaye jEve Diarra kSakadi Foksouma pKamis Dakissia pAthanase Millogo lCédric Moussavou qGams Massi Daniel i…Najib Kissani b c
Journal: Seizure-Européen Journal of Epilepsy
Description:
Epilepsy is a major public health problem in developing countries where eighty percent (80%) of people with epilepsy (PWE) live. Stigma has psychological consequences as well as serious repercussions on patients’ quality of life. This study assesses the perception of health professionals in Africa regarding the stigmatization of PWE. Methodology : This is a multicenter descriptive, cross-sectional study, from 1st August 2020 to 1st September, 2021. Medical practitioners from African countries involved in the management of epilepsy and who agreed to fill out forms were included in the study. Sampling was nonrandom and based on respondent choice. The data were analyzed using the EPI INFO 7 software. Results : A total of two hundred and twenty-nine (229) health workers from twenty-six (26) African countries participated in this survey. 24.89% of the respondents were specialists and 46.72% were neurologists. Ninety-one percent (91%) of practitioners felt that PWE were stigmatised. The main forms of stigma were isolation (68.56%), celibacy (60.70%), unemployment (53.28%), divorce (44.54%) and exclusion (37.99%) %). Community, school and family were recognized as the main places of stigmatization. The fight against this stigma was carried out mainly in hospitals and in isolation in 58.4% and 55.8% of cases, respectively. Only 0.4% of practitioners opted for mass awareness. Conclusion : PWE are victims of various forms of stigmatization, particularly in community settings. Measures aimed at raising awareness of the public are essential to reduce this stigma and improve patients’ quality of life.
Published in 2022
Chorea Hyperglycaemia Basal Ganglia Syndrome, a Neurological Complication of Diabetes: A Case Report
Diabetic Striatopathy, Chorea Hyperglycaemia Basal
Authors: Moussavou Cédrick*, El Bakal Ayoub, Hamid Mohamed, Yassine El Adraoui, Slimani Sarah, Ibrahim Touré, Belghacham Hajar and Bourazza Ahmed
Journal: Crimson Publishers Case Report
Description:
Abnormal involuntary movements induced by hyperglycaemia are epic manifestations of diabetes. They are observed particularly in cases of poorly controlled diabetes. Chorea Hyperglycaemia Basal Ganglia syndrome (C-H-BG) recently referred to as Diabetic Striatopathy (DS) is a rare entity that can lead to misdiagnosis [1]. The prevalence of C-H-BG or DS has been reported to be 1 in 100,000 [2]. Although rare, C-H-BG is often described in non-ketotic hyperglycemia and hypoglycemia [3]. Only rarely has it also been described in ketotic hyperglycaemia. We report a case of diabetic chorea following diabetic ketoacidosis.